Question 1

What are the potential side effects of milnacipran that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia clinical trial (NCT01331109). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for fibromyalgia?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia clinical trial (NCT01331109). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like over the 52 weeks?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia clinical trial (NCT01331109). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or monitoring I will need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia clinical trial (NCT01331109). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia clinical trial (NCT01331109). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be evaluated throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia clinical trial (NCT01331109). Contact the study team or your healthcare provider for specific answers.

What this study is about